Effects of Energy Drinks on Cardiovascular Endpoints (NCT07212803)
Evaluation of Energy Drinks on Electrocardiographic Parameters: A Randomized, Double Blind, Controlled, Crossover, Proof-of-concept Study
🩺 Plain-English Summary (8th-Grade Level)
This is a clinical trial looking at the impact of energy drinks on heart related parameters. The study will enroll 3 participants who will be exposed to 8 different interventions.
Who can join: Review the eligibility criteria below.
Location: University of the Pacific — Stockton, California
Age range: 18 Years to 40 Years
🧪 Interventions in This Study
- Energy Drink A + Placebo Capsule (DIETARY_SUPPLEMENT)
- Placebo Drink + Moxifloxacin Capsule (DRUG)
- Placebo Drink + Caffeine Capsule (DIETARY_SUPPLEMENT)
- Energy Drink B (DIETARY_SUPPLEMENT)
- Control Product + Taurine (DIETARY_SUPPLEMENT)
- Control Product + Caffeine + Taurine (DIETARY_SUPPLEMENT)
- Lower Dose Energy Drink A (DIETARY_SUPPLEMENT)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- University of the Pacific — Stockton, California
📞 Contact the Study Coordinator
Phone: (209) 946-7754
Email: qphan@pacific.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Healthy Volunteers
- Pharmacokinetics and Tolerability of Subcutaneous Dupilumab Coformulated With Berahyaluronidase Alfa and Dupilumab Without Berahyaluronidase Alfa in Healthy Participants — Hialeah, Florida
- A First-in-human, 3-part Study of MRT-8102 in Healthy Participants and Participants at Cardiovascular Risk With Elevated CRP — Miami, Florida
- A Phase 1 Study to Assess the Effect of Itraconazole on ABBV-722 in Healthy Adult Participants — Grayslake, Illinois
- Flavanol-rich Cocoa on Digestive and Cerebrovascular Health in the Colombian Adults — Medellín, Antioquia
- ClinSeq: A Large-Scale Medical Sequencing Clinical Research Pilot Study — Bethesda, Maryland
- A First-in-Human Phase 1 Single-Ascending Dose Study of ABCL575 in Healthy Participants — Mount Royal, Quebec
Explore by condition: All Healthy Volunteers clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.